| 05/06/2026 7:00 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 6:50 AM | Novavax (1000694) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/30/2026 11:07 AM | Novavax (1000694) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/28/2026 4:00 PM | Newton Charles W. (1866219) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/27/2026 12:02 PM | BANK OF AMERICA CORP /DE/ (70858) Filed by Novavax (1000694) Subject | Form SCHEDULE 13G/A | |
| 04/27/2026 9:09 AM | Novavax (1000694) Filer | Form ARS | |
| 04/27/2026 7:00 AM | Novavax (1000694) Filer | Form DEF 14A | |
| 04/27/2026 7:00 AM | Novavax (1000694) Filer | Form DEFA14A | |
| 04/16/2026 5:13 PM | Novavax (1000694) Issuer Walker Robert Edward (2127840) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 4:40 PM | Novavax (1000694) Issuer Walker Robert Edward (2127840) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/08/2026 5:00 AM | Novavax (1000694) Subject SHAH CAPITAL MANAGEMENT (1383838) Filed by | Form SCHEDULE 13D/A | |
Get the Latest News and Ratings for NVAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Novavax and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/09/2026 5:06 PM | Novavax (1000694) Issuer O'Hara Elaine (1968045) Reporting | Form 4/A | |
| 03/09/2026 5:08 PM | Jacobs John C (1820836) Reporting Novavax (1000694) Issuer | Form 4/A | |
| 03/09/2026 5:09 PM | Casey Mark J (1415297) Reporting Novavax (1000694) Issuer | Form 4/A | |
| 03/09/2026 5:11 PM | Draghia-Akli Ruxandra (2041719) Reporting Novavax (1000694) Issuer | Form 4/A | |
| 03/09/2026 5:12 PM | Kelly James Patrick (1506314) Reporting Novavax (1000694) Issuer | Form 4/A | |
| 03/09/2026 5:13 PM | Kelly James Patrick (1506314) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 5:00 AM | Draghia-Akli Ruxandra (2041719) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 5:01 AM | Casey Mark J (1415297) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 5:02 AM | Novavax (1000694) Issuer O'Hara Elaine (1968045) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 5:03 AM | Jacobs John C (1820836) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 5:04 AM | Kelly James Patrick (1506314) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 8:33 PM | Casey Mark J (1415297) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 8:34 PM | Novavax (1000694) Issuer O'Hara Elaine (1968045) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 8:35 PM | Kelly James Patrick (1506314) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 8:37 PM | Jacobs John C (1820836) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/26/2026 7:02 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/26/2026 6:33 AM | Novavax (1000694) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/11/2026 1:11 PM | BANK OF AMERICA CORP /DE/ (70858) Filed by Novavax (1000694) Subject | Form SCHEDULE 13G | |
| 02/09/2026 6:56 AM | Novavax (1000694) Subject STATE STREET CORP (93751) Filed by STATE STREET CORP (93751) Filed by | Form SCHEDULE 13G | |
| 01/26/2026 6:57 PM | Jacobs John C (1820836) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 5:59 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 7:01 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/13/2025 4:23 PM | Draghia-Akli Ruxandra (2041719) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/06/2025 6:47 AM | Novavax (1000694) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/06/2025 7:00 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/04/2025 5:02 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2025 3:30 PM | Novavax (1000694) Issuer Rodgers Richard J (1313397) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 6:00 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/14/2025 6:45 AM | Novavax (1000694) Subject SHAH CAPITAL MANAGEMENT (1383838) Filed by | Form SCHEDULE 13D/A | |
| 10/07/2025 6:00 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
| 08/27/2025 3:38 PM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/27/2025 3:40 PM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/21/2025 6:48 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/06/2025 7:04 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/06/2025 6:47 AM | Novavax (1000694) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 06/24/2025 5:37 PM | DOUGLAS RICHARD (1021015) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2025 5:39 PM | King Rachel K. (1589712) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2025 5:40 PM | MOTT DAVID M (1219871) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2025 5:40 PM | Novavax (1000694) Issuer Rodgers Richard J (1313397) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2025 5:35 PM | MCGLYNN MARGARET G (1215126) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2025 5:36 PM | Alton Gregg H (1334682) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2025 5:03 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/13/2025 8:39 PM | MOTT DAVID M (1219871) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/13/2025 8:40 PM | Novavax (1000694) Issuer Rodgers Richard J (1313397) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/13/2025 8:41 PM | King Rachel K. (1589712) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/13/2025 8:36 PM | DOUGLAS RICHARD (1021015) Reporting Novavax (1000694) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2025 6:01 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/19/2025 6:34 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/08/2025 7:26 AM | Novavax (1000694) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/08/2025 6:59 AM | Novavax (1000694) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |